0001145549-20-060531.txt : 20201014 0001145549-20-060531.hdr.sgml : 20201014 20201014141403 ACCESSION NUMBER: 0001145549-20-060531 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200731 FILED AS OF DATE: 20201014 DATE AS OF CHANGE: 20201014 EFFECTIVENESS DATE: 20201014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN FUNDS TAX-EXEMPT FUND OF NEW YORK CENTRAL INDEX KEY: 0001496999 IRS NUMBER: 273101752 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22448 FILM NUMBER: 201238799 BUSINESS ADDRESS: STREET 1: 6455 IRVINE CENTER DRIVE CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 213-486-9501 MAIL ADDRESS: STREET 1: 333 S HOPE ST - 55TH FLOOR (GYR) CITY: LOS ANGELES STATE: CA ZIP: 90071 0001496999 S000030189 AMERICAN FUNDS TAX-EXEMPT FUND OF NEW YORK C000092891 Class A NYAAX C000092893 Class C NYACX C000092894 Class F-1 NYAEX C000092895 Class F-2 NYAFX C000180002 Class F-3 TFNYX C000189479 Class T TATEX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0001496999 XXXXXXXX true false false N-1A true AMERICAN FUNDS TAX-EXEMPT FUND OF NEW YORK 811-22448 0001496999 C0V4BQZZVIEYRMW6YD58 6455 Irvine Center Drive Irvine 92618 US-CA US 9499755000 Capital Research and Management Company 6455 Irvine Center Drive Irvine 92618 9499755000 Fund accounting and transaction settlement records N N N-1A 1 Y Alexandra Trower N/A N Mary Davis Holt N/A N Merit E. Janow N/A N Mike C. Gitlin N/A Y Nariman Farvardin N/A N Paul S. Williams N/A N R. Clark Hooper N/A N James G. Ellis N/A N William H. Baribault N/A N Karl J. Zeile N/A Y Margaret Spellings N/A N Jane M. Scofield N/A 333 South Hope Street 54th Floor Los Angeles 90071 XXXXXX Y N N N N N American Funds Distributors, Inc. 8-17168 000006247 N/A Y N PricewaterhouseCoopers LLP 00238 5493002GVO7EO8RNNS37 N N N N N N N AMERICAN FUNDS TAX-EXEMPT FUND OF NEW YORK S000030189 C0V4BQZZVIEYRMW6YD58 N 6 0 0 N/A N N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N Capital Research and Management Company 801-8055 000110885 M02M7XSKLMK96MWKNF95 N American Funds Service Company 84-00316 N/A Y N N Bloomberg L.P. 549300B56MD0ZC402L06 N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N N The Bank of New York Mellon N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N American Funds Service Company 84-00316 SEC File number Y N N Capital Research and Management Company M02M7XSKLMK96MWKNF95 Y N N American Funds Distributors, Inc. 8-17168 000006247 N/A 0.0 0.000000000000 Bank of America, N.A. 8-69787-1 000283942 B4TYDEB6GKMZO031MB27 87196556.000000000000 Samuel A. Ramirez & Company, Inc. 8-19014-1 000006963 254900CBKVW7O2ENQA21 5384030.000000000000 Goldman Sachs & Co. LLC 8-00129-1 000000361 FOR8UP27PHTHYVLBNG30 57158013.000000000000 J.P. Morgan Securities LLC 8-35008-1 000000079 ZBUT11V806EZRVTWT807 35184386.000000000000 U.S. Bancorp Investments, Inc. 8-35359-1 000017868 H85Z6XZP8B10ES0M2G89 34670000.000000000000 Citigroup Global Markets Inc. 8-08177-1 000007059 MBNUM2BPBDO7JBLYG310 22059696.000000000000 Barclays Bank PLC N/A N/A G5GSEF7VJP5I7OUK5573 GB 19758058.000000000000 RBC Capital Markets LLC 8-45411-1 000031194 549300LCO2FLSSVFFR64 17471431.000000000000 Morgan Stanley & Co. LLC 8-15869-1 000008209 9R7GPTSO7KV3UQJZQ078 7980608.000000000000 Jefferies & Company Inc. 8-15074-1 000002347 58PU97L1C0WSRCWADL48 6976241.000000000000 333354138.000000000000 N 289211490.000000000000 Uncommitted 1500000000.000000000000 N N N N true INTERNAL CONTROL RPT 2 tefnyinternalcontrol.htm TEFNY INTERNAL CONTROL 07/31/2020 PDFtoHTML Conversion Output

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of American Funds Tax-Exempt Fund of New York

In planning and performing our audit of the financial statements of American Funds Tax-Exempt Fund of New York (the "Fund") as of and for the year ended July 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of July 31, 2020.

PricewaterhouseCoopers LLP, 601 South Figueroa Street, Los Angeles, CA 90017 T: (213) 356-6000, F: (813) 637 4444, www.pwc.com/us

This report is intended solely for the information and use of the Board of Trustees of American Funds Tax- Exempt Fund of New York and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Los Angeles, California

September 14, 2020

2